// App-Quantinova.ai

WP278 2016 ASA : Effects of Prasugrel on Cerebral Infarction and Neurological Deficits in a Non-human Primate Model of Thrombotic Stroke

Researchers

Presenter

  • Kousaku Ohno

Principal Investigators

  • Joseph A. Jakubowski

  • Makoto Mizuno

  • Atsuhiro Sugidachi

Medical Centers

  • N/A

Locations

  • N/A

Companies

  • Daiichi Sankyo Compa

  • Eli Lilly and Compan

Study Components

Therapeutic Area

  • Central Nervous System (CNS)

Disease

  • Ischemic stroke

  • Venous thrombosis

  • Stroke

Biomarkers

  • N/A

Drug/Treatment

  • Prasugrel

  • Rose bengal sodium

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved